SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000131
Filing Date
2016-05-04
Accepted
2016-05-04 16:06:55
Documents
15
Period of Report
2016-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201605048xkdoc.htm 8-K 36276
2 PRESS RELEASE pdli-201605048xkex991.htm EX-99.1 160786
3 PRESENTATION pdli-201605048xkex992.htm EX-99.2 4125
4 INFORMATION SHEET pdli-201605048xkex993.htm EX-99.3 575400
5 PRESS RELEASE pdli-201605048xkex994.htm EX-99.4 12460
6 a20160504slide1.jpg GRAPHIC 126629
7 a20160504slide2.jpg GRAPHIC 236372
8 a20160504slide3.jpg GRAPHIC 126491
9 a20160504slide4.jpg GRAPHIC 150716
10 a20160504slide5.jpg GRAPHIC 80617
11 a20160504slide6.jpg GRAPHIC 126109
12 a20160504slide7.jpg GRAPHIC 157538
13 a20160504slide8.jpg GRAPHIC 114427
14 pdl-logoa04a01a01a01a02a08.jpg GRAPHIC 59351
15 pdllogo2016a01.jpg GRAPHIC 5218
  Complete submission text file 0000882104-16-000131.txt   2421251
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 161619323
SIC: 2836 Biological Products, (No Diagnostic Substances)